BioSpace News Archive

IntraOp Medical Corporation announced today that doctors at Vanderbilt University Medical Center (VUMC) treated a pancreatic cancer patient using IntraOp® Mobetron® Intra-Operative Radiation Therapy (IORT).

The efficacy of Novarad’s VisAR Augmented Reality Guidance system demonstrated an angular error of 1.3° (close to what can be achieved with a robot and below the 2° standard for stereotactic cranial navigation set by the FDA in a recent published article in the peer reviewed journal Neurosurgery for simulated external ventricular drain (EVD) placement.

Bayer announced the acquisition of the global strategic imaging AI platform and solutions provider Blackford Analysis Ltd.

OpGen, Inc. today announced preliminary unaudited revenue for 2022.

Teon Therapeutics today announced that it has entered into the clinical trial collaboration agreement with Merck (known as MSD outside the United States and Canada), a leader in immuno-oncology (IO).

Arch Therapeutics, Inc. today announced the formation of a medical advisory board (the “ Medical Advisory Board ”) comprised of respected wound care professionals across multiple medical specialties, including vascular surgery, podiatric medicine, and foot and ankle surgery.

Pyramid Biosciences, Inc. has announced its participation this week in the B. Riley Securities 3rd Annual Oncology Conference.

Pathalys Pharma, Inc., a private, late-stage biopharma company co-founded by Catalys Pacific and DaVita Venture Group, and Launch Therapeutics (Launch Tx), a clinical development company, today announced a collaboration to advance phase 3 clinical trials for upacicalcet (designated PLS240 for clinical trials) for the treatment of secondary hyperparathyroidism (SHPT) in patients on hemodialysis.

The Lupus Research Alliance (LRA) is pleased to announce the appointment of Stacie J. Bell, PhD as Executive Vice President to lead Lupus Therapeutics, the organization’s clinical research affiliate.

Charles River Laboratories International, Inc. (NYSE: CRL) and Rznomics Inc. today announced a viral vector contract development and manufacturing organization (CDMO) partnership.